University of California - Los Angeles
Los Angeles, California, 90024, United States
NCT Number: NCT00249613
The purpose of this study is to determine whether substance abuse treatment designed specifically for drug-dependent women offenders provides better outcomes than standard drug court treatment (mixed-gender programs).
Looking for future studies?
Notify Me18 year–75 year
Female
Interventional
Not applicable
Los Angeles, California, 90024, United States
In this five-year study, a total of 300 women entering court-referred treatment throughout Los Angeles County and who agree to participate in the study will be randomly assigned to a women-focused or to a mixed-gender outpatient treatment program. The study will assess the impact of women-focused substance abuse treatment using outcome measures including recidivism, substance abuse and relapse, and social adjustment (e.g., employment, parenting behaviors, psychological improvement, and HIV risk reduction behaviors), compared to the impact of traditional mixed-gender programs. Assessments will occur at baseline and at 1 month, 12 months, and 24 months after admission.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Gender-responsive treatment for women only
Time frame: baseline and 1-year follow-up
Time frame: 12 Months
Time frame: 12 Months
Substance use in past 30 days at 12 months post intake
Time frame: 12 month post intake
Predictors of change in employment at 12 months post intake: GEE - comparison of Women-Only vs. Mixed-Gender treatment models
University of California, Los Angeles
Other
Gender-Responsive Treatment for Women Offenders
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07184164
Chemically-Induced Disorders, Mental Disorders
Shibīn al Kawm, Menoufia, Egypt
View Trial DetailsNCT02872467
Chemically-Induced Disorders, Mental Disorders
Chapel Hill, North Carolina, United States
View Trial DetailsNCT02740881
Chemically-Induced Disorders, Mental Disorders
Eugene, Oregon, United States
View Trial DetailsNCT02715206
Chemically-Induced Disorders, Mental Disorders
Columbus, Ohio, United States
View Trial Details